This month, our Chief Medical Officer Prof. dr. Jorrit-Jan Verlaan and our Director Clinical Operations Suzanne Bruins visited a potential clinical trial site as part of the preparation for our adaptive Phase II/III study, subject to regulatory review and clinical outcomes.

Meeting with experienced centers early in the process helps us align on the protocol and prepare for smooth study start-up.

Each step moves us closer to generating the evidence needed to offer patients effective, non-opioid pain control after spine surgery.